Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model

Human Immunology

Volumn 69, Issue 10, 2008, Pages 605-613

  Mathew, James M ^a,b   Blomberg, Bonnie ^b   Ricordi, Camillo ^b,c   Esquenazi, Violet ^b,d   Miller, Joshua ^a,b,d,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Bone marrow; Human islet model; SCID; Tolerance; Transplantation

Indexed keywords

CD3 ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; KIDNEY; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL LYMPHOCYTE; PORTAL VEIN; PRIORITY JOURNAL; SCID MOUSE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULINS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTES; MICE; MICE, INBRED NOD; MICE, SCID; MODELS, ANIMAL; TIME FACTORS;

EID: 54549103415     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.07.003     Document Type: Article

References (41)

1. Billingham R.E., Brent L., and Medawar P.B. Actively acquired tolerance of foreign cells. Nature 172 (1953) 603
2. Barber W.H., Mankin J.A., Laskow D.A., Deierhoi M.H., Julian B.A., Curtis J.J., and Diethelm A.G. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 51 (1991) 70
3. Caridis D.T., Liegeois A., Barrett I., and Monaco A.P. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transplant Proc 5 (1973) 671
4. Monaco A.P., Clark A.W., Wood M.L., Sahyoun A.I., Codish S.D., and Brown R.W. Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: Case report of an initial attempt. Surgery 79 (1976) 384
5. Salvatierra Jr. O., Vincenti F., Amend W., Potter D., Iwaki Y., Opelz G., et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 192 (1980) 543
6. Sharabi Y., and Sachs D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169 (1989) 493
7. Slavin S., Strober S., Fuks Z., and Kaplan H.S. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science 193 (1976) 1252
8. Starzl T.E., Demetris A.J., Trucco M., Murase N., Ricordi C., Ildstad S., et al. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance. Hepatology 17 (1993) 1127
9. Elwood E.T., Larsen C.P., Maurer D.H., Routenberg K.L., Neylan J.F., Whelchel J.D., O'Brien D.P., and Pearson T.C. Microchimerism and rejection in clinical transplantation. Lancet 349 (1997) 1358
10. Wood K., and Sachs D.H. Chimerism and transplantation tolerance: Cause and effect. Immunology Today 17 12 (1996) 584
11. Schlitt H.J., Hundrieser J., Ringe B., and Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 330 (1994) 646
12. Sivasai K.S., Alevy Y.G., Duffy B.F., Brennan D.C., Singer G.G., Shenoy S., et al. Peripheral blood microchimerism in human liver and renal transplant recipients: Rejection despite donor-specific chimerism [Published erratum appears in Transplantation 1997;64:1636]. Transplantation 64 (1997) 427
13. SivaSai K.S., Jendrisak M., Duffy B.F., Phelan D., Ravenscraft M., Howard T., and Mohanakumar T. Chimerism in peripheral blood of sensitized patients waiting for renal transplantation: Clinical implications. Transplantation 69 (2000) 538
14. Mathew J.M., Garcia-Morales R., Fuller L., Rosen A., Ciancio G., Burke G.W., et al. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses. Transplantation 70 (2000) 1675
15. Mathew J.M., and Miller J. Immunoregulatory role of chimerism in clinical organ transplantation. Bone Marrow Transplant 28 (2001) 115
16. Mathew J.M., Garcia-Morales R.O., Carreno M., Jin Y., Fuller L., Blomberg B., et al. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation. Transpl Immunol 11 (2003) 307
17. Ciancio G., Miller J., Garcia-Morales R.O., Carreno M., Burke III G.W., Roth D., et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 71 (2001) 827
18. Garcia-Morales R., Carreno M., Mathew J., Cirocco R., Zucker K., Ciancio G., et al. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation 65 (1889) 956
19. Fontes P.A., Ricordi C., Rao A.S., Rybka W.B., Dodso S.F., Broznick B., et al. Human vertebral bodies as a source of bone marrow cell augmentation in whole organ allografts. In: Ricordi C., et al. (Ed). Methods in Cell Transplantation (1995), R.G. Landes, Austin
20. Mathew J.M., Carreno M., Fuller L., Ricordi C., Tzakis A., Esquenazi V., and Miller J. Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses. Transplantation 63 (1997) 686
21. Mathew J.M., Carreno M., Fuller L., Ricordi C., Kenyon N., Tzakis A.G., et al. In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation. Transplantation 68 (1999) 1172
22. Mathew J.M., Fuller L., Carreno M., Garcia-Morales R., Burke III G.W., Ricordi C., et al. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses. Transplantation 70 (2000) 1752
23. Mathew J.M., Carreno M., Fuller L., Burke III G.W., Ciancio G., Ricordi C., et al. Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. Transplantation 74 (2002) 846
24. Mathew J.M., Carreno M., Zucker K., Fuller L., Kenyon N., Esquenazi V., et al. Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation. Transplantation 65 (1998) 947
25. Shearer G. Graft versus host disease. In: Colligan J.E., et al. (Ed). Current Protocols in Immunology (1991), Wiley Interscience, New York Section 4.3
26. Berney T., Molano R.D., Pileggi A., Cattan P., Li H., Ricordi C., and Inverardi L. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes. Transplantation 72 (2001) 133
27. Greiner D.L., Shultz L.D., Yates J., Appel M.C., Perdrizet G., Hesselton R.M., et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 146 (1995) 888
28. Gysemans C., Waer M., Laureys J., Depovere J., Pipeleers D., Bouillon R., and Mathieu C. Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells. Clin Exp Immunol 121 (2000) 557
29. Kawamura T., Niguma T., Fechner Jr. J.H., Wolber R., Beeskau M.A., Hullett D.A., Sollinger H.W., and Burlingham W.J. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor. Transplantation 53 (1992) 659
30. MacKenzie D.A., Sollinger H.W., and Hullett D.A. Acute graft rejection of human fetal pancreas allografts using donor-specific human peripheral blood lymphocytes in the SCID mouse. Transplantation 61 (1996) 1461
31. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., and Weissman I.L. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241 (1988) 1632
32. Mosier D.E., Gulizia R.J., Baird S.M., and Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335 (1988) 256
33. Murray A.G., Petzelbauer P., Hughes C.C., Costa J., Askenase P., and Pober J.S. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A 91 (1994) 9146
34. Shiroki R., Poindexter N.J., Woodle E.S., Hussain M.S., Mohanakumar T., and Scharp D.W. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection. Transplantation 57 (1994) 1555
35. Shiroki R., Nazirrudin B., Hoshinaga K., Naide Y., Scharp D.W., and Mohanakumar T. Human peripheral blood lymphocyte-reconstituted, severe combined immunodeficient mice as a model for porcine islet xenograft rejection in human beings. Artif Organs 20 (1996) 878
36. Tary-Lehmann M., Saxon A., and Lehmann P.V. The human immune system in hu-PBL-SCID mice. Immunol Today 16 (1995) 529
37. Anderson B.E., McNiff J., Yan J., Doyle H., Mamula M., Shlomchik M.J., and Shlomchik W.D. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 112 (2003) 101
38. Drobyski W.R., Majewski D., Ozker K., and Hanson G. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. J Immunol 161 (1998) 2610
39. Eguchi H., Knosalla C., Lan P., Cheng J., Diouf B., Wang L., et al. T cells from presensitized donors fail to cause graft-versus-host disease in a pig-to-mouse xenotransplantation model. Transplantation 78 (2004) 1609
40. Burt R.K., Marmont A., Oyama Y., Slavin S., Arnold R., Hiepe F., et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 54 (2006) 3750
41. Mineo D., Ricordi C., Xu X., Pileggi A., Garcia-Morales R., Khan A., et al. Combined islet and hematopoietic stem cell allotransplantation: A clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant 8 (2008) 29